Skip to main content

Table 3 Neoadjuvant therapy

From: Potential risk of residual cancer cells in the surgical treatment of initially unresectable pancreatic carcinoma after chemoradiotherapy

Chemo(radio)therapy

Regimen

n

Period of therapy (month)

Chemotherapy (IV)

GEM + S-1

10

8.5 (5–32)

 

GEM

1

11

Chemotherapy (TA)

GEM + 5-FU

3

7/34/44

Chemoradiotherapy

GEM + S-1

2

7/16

 

GEM + 5-FU

1

8

 

GEM

1

32

   

9 (5–44)

  1. GEM gemcitabine, 5-FU 5-fluorouracil